Recombinant Human Follicle-stimulating Hormone Research:CAGR of 5.1% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Recombinant Human Follicle-stimulating Hormone- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.



The global market for Recombinant Human Follicle-stimulating Hormone was estimated to be worth US$ 1154 million in 2024 and is forecast to a readjusted size of US$ 1680 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.



【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】

https://www.qyresearch.com/reports/3549645/recombinant-human-follicle-stimulating-hormone



Recombinant Human Follicle-stimulating Hormone Market Summary

Follicle stimulating hormone (FSH) is a hormone synthesised and secreted by gonadotropes in the anterior pituitary gland. FSH and LH act synergistically in reproduction. Recombinant human Follicle Stimulating Hormone is a heterodimeric protein consisting of 92 amino acids alpha chain and 111 amino acids beta chain. FSH migrates as an approximately 27 kDa glycoprotein. Optimized DNA sequence encoding human FSH mature chain was expressed in CHO.

The recombinant human follicle-stimulating hormone (rhFSH) market is experiencing steady growth, driven by advancements in reproductive medicine, particularly in assisted reproductive technologies (ART) such as in vitro fertilization (IVF). Increased awareness of infertility issues and growing demand for effective fertility treatments are key factors propelling market expansion. The rising incidence of delayed pregnancies, especially in developed countries, has contributed to a surge in the use of fertility drugs, including rhFSH. Furthermore, the availability of biosimilars has enhanced market competition, driving down costs and improving accessibility. The market is also benefiting from innovations in drug delivery systems, such as pre-filled pens and injectors, which improve patient convenience and adherence. Geographic regions such as North America and Europe dominate the market, though there is a notable rise in demand in Asia-Pacific, fueled by increasing disposable incomes, evolving healthcare infrastructure, and a growing awareness of fertility solutions. However, challenges such as high treatment costs, regulatory hurdles, and potential side effects of hormone therapies remain. Despite these factors, the overall market outlook for recombinant human FSH remains positive, with continued investment in research and development expected to drive future growth.

According to the new market research report "Global Recombinant Human Follicle-stimulating Hormone Market Report 2024-2030", published by QYResearch, the global Recombinant Human Follicle-stimulating Hormone market size is projected to grow from USD 1460.9 million in 2024 to USD 1966.4 million by 2030, at a CAGR of 5.1% during the forecast period.

Global Recombinant Human Follicle-stimulating Hormone MarketSize(US$ Million), 2019-2030
250116-165616.webp (14 KB)

Above data is based on report from QYResearch: Global Recombinant Human Follicle-stimulating Hormone Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.



Global Recombinant Human Follicle-stimulating Hormone Top7Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)
250116-165655.webp (15 KB)

Above data is based on report from QYResearch: Global Recombinant Human Follicle-stimulating Hormone Market Report 2024-2030 (published in 2024). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Recombinant Human Follicle-stimulating Hormone include Merck KGaA, Organon, Gedeon Richter, Ferring, Changchun High-Tech, Theramex, Qilu Pharmaceutical, etc. In 2023, the global top five players had a share approximately 97.0% in terms of revenue.



Recombinant Human Follicle-stimulating Hormone,Global Market Size, Split by Product Segment
250116-165719.webp (18 KB)

Based on or includes research from QYResearch: Global Recombinant Human Follicle-stimulating Hormone Market Report 2024-2030.

In terms of product type, currently 75IU is the largest segment, hold a share of 44.4%.





In terms of product application, currently Women is the largest segment, hold a share of 73.2%.,







The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.



The Recombinant Human Follicle-stimulating Hormone market is segmented as below:

By Company

Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical



Segment by Type

75IU
150IU
Others



Segment by Application

Infertility Treatment
Assisted Reproductive Technology



Each chapter of the report provides detailed information for readers to further understand the Recombinant Human Follicle-stimulating Hormone market:

Chapter 1: Introduces the report scope of the Recombinant Human Follicle-stimulating Hormone report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)

Chapter 2: Detailed analysis of Recombinant Human Follicle-stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)

Chapter 3: Provides the analysis of various Recombinant Human Follicle-stimulating Hormone market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)

Chapter 5: Sales, revenue of Recombinant Human Follicle-stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)

Chapter 6: Sales, revenue of Recombinant Human Follicle-stimulating Hormone in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.



Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Recombinant Human Follicle-stimulating Hormone competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Recombinant Human Follicle-stimulating Hormone comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Recombinant Human Follicle-stimulating Hormone market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.



Other relevant reports of QYResearch:

Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2025
Global Recombinant Human Follicle-stimulating Hormone Market Insights, Forecast to 2030
Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2024
Global and United States Recombinant Human Follicle Stimulating Hormone Injection Market Report & Forecast 2024-2030
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
Global Recombinant Human Follicle Stimulating Hormone Injection Market Insights, Forecast to 2030
Recombinant Human Follicle Stimulating Hormone Injection- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Recombinant Human Follicle-stimulating Hormone - Global Market Insights and Sales Trends 2024
Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2023
Global Recombinant Human Follicle-stimulating Hormone Market Insights, Forecast to 2029
Global Recombinant Human Follicle-stimulating Hormone Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Global and United States Recombinant Human Follicle-stimulating Hormone Market Report & Forecast 2022-2028

About Us：

QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)  
JP: https://www.qyresearch.co.jp

This release was published on openPR.